[Treatment of pulmonal hypertension].
While the clinical classification of diseases with pulmonary hypertension (PH) has remained fairly stable in recent years, the treatment options have improved significantly. In addition to the General measures (vaccinations, physical training) new recommendations for supportive therapy (administration of diuretics, iron supplementation and oral anticoagulant) exist currently. Some new substances (mostly in the indication pulmonary arterial hypertension) have been admitted to the targeted drug treatment in recent years. For the first time, exist a approved drug therapy for the non-operable and residual chronic thromboembolic pulmonary hypertension.
Bereich Pneumologie / Infektiologie, Klinik für Innere Medizin B, Unversitätsmedizin Greifswald.
Ralf
R
Ewert
D000284:Administration, Oral; D000925:Anticoagulants / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004232:Diuretics / Q000627:therapeutic use; D005081:Exercise Therapy; D006801:Humans; D006976:Hypertension, Pulmonary / Q000145:classification / Q000209:etiology / Q000628:therapy*; D007501:Iron / Q000627:therapeutic use; D011655:Pulmonary Embolism / Q000150:complications / Q000628:therapy; D014611:Vaccination
D000925:Anticoagulants; D000959:Antihypertensive Agents; D004232:Diuretics; D007501:Iron